J & J submits Ebola vaccine regimen to WHO for EUAL

Johnson& Johnson ’s (J&J) Janssen Vaccines& Prevention has submitted its investigational preventive Ebola prime-boost vaccine regimen for review to the World Health Organisation (WHO) for Emergency Use Assessment and Listing (EUAL).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news